Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Soft Tissue Neoplasms × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 31 Leiomyosarcoma 11 Ovarian Neoplasms 10 Liposarcoma 10 Neoplasms 5 Sarcoma, Ewing 4 Liposarcoma, Myxoid 4 Sarcoma, Synovial 3 Rhabdomyosarcoma 3 Neoplasm Metastasis 3 Histiocytoma, Malignant Fibrous 3 Solitary Fibrous Tumors 2 Sarcoma, Alveolar Soft Part 2 Prostatic Neoplasms 2 Osteosarcoma 2 Neurofibrosarcoma 2 Mesothelioma, Malignant 2 Malignant mesenchymal tumor 2 Ichthyosis, X-Linked 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2 Fibrosarcoma 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Bone Neoplasms 2 Wilms Tumor 1 Uterine Neoplasms 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Soft Tissue Neoplasms 1 Sarcoma, Endometrial Stromal 1

Interventions

temsirolimus 1 binimetinib 1 Valproic Acid 1 Trabectedin 1 Specimen Handling 1 Sirolimus 1 Immunoglobulin G 1 Enoxaparin 1 Disulfides 1 Cetuximab 1 Biopsy 1 Bevacizumab 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02066675 2018-04-11

TR1US

Italian Sarcoma Group

Phase 2 Completed

Neoplasm Metastasis, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡